Rodrigues H G, Pinto T C A, Barros R R, Teixeira L M, Neves F P G
Department of Microbiology and Parasitology,Universidade Federal Fluminense,Niterói, Rio de Janeiro,Brazil.
Department of Medical Microbiology,Universidade Federal do Rio de Janeiro,Rio de Janeiro,Brazil.
Epidemiol Infect. 2017 Jun;145(8):1720-1726. doi: 10.1017/S0950268817000449. Epub 2017 Mar 7.
We performed two different approaches (broth enrichment step prior to culture (BEC) and PCR (BEPCR)) for detecting Streptococcus pneumoniae from nasopharyngeal specimens collected from 242 children aged <6 years attending one hospital (n = 140) and one childcare centre (n = 102) in a major urban area in Brazil. These specimens were collected immediately before the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) and the 13-valent vaccine (PCV13) for routine use in Brazil. Results were compared with previous findings obtained with direct culture (DC) on a selective medium. Colonisation prevalence was 58·3% (n = 141), being higher among children attending the childcare centre (62·7% vs. 55%). The culture-based methods (DC and BEC) enabled the detection of S. pneumoniae in 119 (49·2%) and 115 (47·5%) children, respectively. The PCR-based method (BEPCR) was more sensitive and 137 (56·6%) carriers were identified. Twenty-six serogroups/serotypes were identified, predominantly 6B, 19F, 14, 6A, 15C and 23F. Multiple colonisation was observed in 13 (5·4%) children. The estimated serotypes coverage of available PCVs was 40·4% for the 10-valent (included in the Brazilian immunisation programme) and 55·8% for the 13-valent (only available in private clinics). The use of robust approaches to obtain a more realistic insight about the asymptomatic carrier status is of paramount importance to estimate and assess the impact of vaccine implementation. The combination between culture-based and molecular methods constitutes a suitable strategy.
我们采用了两种不同方法(培养前肉汤富集步骤(BEC)和聚合酶链反应(BEPCR)),以检测来自巴西一个主要城市地区一家医院(n = 140)和一家日托中心(n = 102)的242名6岁以下儿童鼻咽标本中的肺炎链球菌。这些标本是在巴西常规使用10价肺炎球菌结合疫苗(PCV10)和13价疫苗(PCV13)之前立即采集的。将结果与之前在选择性培养基上进行直接培养(DC)获得的结果进行比较。定植患病率为58.3%(n = 141),在日托中心儿童中更高(62.7%对55%)。基于培养的方法(DC和BEC)分别在119名(49.2%)和115名(47.5%)儿童中检测到肺炎链球菌。基于聚合酶链反应的方法(BEPCR)更敏感,识别出137名(56.6%)携带者。鉴定出了26个血清群/血清型,主要为6B、19F、14、6A、15C和23F。在13名(5.4%)儿童中观察到多重定植。对于10价疫苗(纳入巴西免疫规划),可用肺炎球菌结合疫苗的估计血清型覆盖率为40.4%,对于13价疫苗(仅在私立诊所可用)为55.8%。采用可靠方法以更实际地了解无症状携带者状态对于评估疫苗实施的影响至关重要。基于培养的方法和分子方法相结合是一种合适的策略。